Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), COPE CE Credit(s)
During this myCME Expert Perspectives activity, 2 clinical experts review the incidence, prevalence, and pathophysiology of VKC, as well as the clinical features and differential diagnosis of the condition.
Dry eye disease management is challenging due to its complex pathogenesis and heterogenous clinical presentation. Clinicians should review the 2019 American Academy of Ophthalmology recommendations for the management of dry eye, which stratify patients by disease severity and suggest a stepwise approach to treatment. Additionally, an understanding of the agents available including their MOA, and efficacy/safety data is needed in order to treat dry eye according to etiology and not just severity.
Although the multifactorial causes of multiple sclerosis (MS) are not known, an improved understanding of the neuroimmunologic pathogenesis has led to the development of a wide variety of disease-modifying treatments (DMTs). While there is no cure for MS, these treatments can reduce disease activity and delay MS progression and disability.
Medications such as immunomodulatory and immunosuppressive disease-modifying therapies (DMTs) can delay this damage and slow the resulting progressive phase, thus helping maintain quality of life for patients with Multiple Sclerosis. To make an informed decision, clinicians need to understand the rationale behind medication choices and the risks and benefits of DMTs available.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
This CME Outfitters webcast will feature an expert panel discussion that focuses on the efficacy and safety of recently approved DMTs, implementing cognitive assessment into routine monitoring for patients with MS, and emerging data on the effects of MS therapies on cognition.
AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), AANP Contact Hour(s), CE for Pharmacists
A rising geriatric population, increased life expectancy, and the anticipated launch of novel molecules are driving the need for continuing medical education for clinicians treating neurological disorders. This BRAINWeek Highlights activity presents three timely and relevant presentations focused on the most commonly diagnosed CNS conditions.
AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, ANCC Contact Hour(s)
In this CME Outfitters Live and OnDemand webcast, animated 3-D models will illustrate the immune processes that contribute to MS pathology and serve as targets for immune-directed therapies. Expert faculty will review clinical data supporting the efficacy and safety of novel and emerging immune-directed therapies as well as the role of biomarkers in assessing disease progression and guiding treatment decisions in patients with MS.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
This activity provides an overview of the role of the innate and adaptive immune systems in the development and progression of multiple sclerosis (MS), while exploring the therapeutic implications of immune dysfunction. MS immunotherapies are reviewed, with a focus on their mechanisms of action and immune-related toxicities. Patient case studies are included to illustrate considerations in the selection and sequencing of therapy and the management of immune-related toxicities.
0.5 CME credit. Expires: 12/29/21. Evidence-based first-line MG treatment strategies will be reviewed, as will the potential limitations of these therapies.
During this myCME ™ Expert Perspectives roundtable discussion, 3 distinguished faculty discuss new understandings of the immunologic processes involved in the development of myasthenia gravis (MG,) the novel agents that target these processes, and the most recent clinical evidence for efficacy and safety. The faculty will also discuss the potential advantages of newer agents over conventional MG agents.
AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
This online session will explore differences in the prevalence and incidence of Multiple Sclerosis based on gender and race, as well as the implications for treatment selection and management of side effects.
3 interactive patient cases that enable clinicians to evaluate and integrate real world evidence and expert guidance when tailoring and assessing the efficacy of treatment plans for patients with multiple sclerosis.
Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.
